Clinical Trial Update: TMS-related Measures as Biomarker of Cognitive Impairment in PD [NA]

View source ↗

Summary

This clinical trial investigates TMS-related measures as biomarkers of cognitive impairment in Parkinson disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Azienda Sanitaria Universitaria Integrata del Trentino | Conditions: Parkinson Disease | NA | Status: RECRUITING